Results 101 to 110 of about 67,047,750 (228)

Effects of carvedilol therapy in patients with heart failure with mid-range and preserved ejection fraction

open access: yes, 2019
Uvod: Prema posljednjim smjernicama, još uvijek nema preporuka za nijedan lijek za liječenje bolesnika sa zatajivanjem srca sa srednje očuvanom i očuvanom ejekcijskom frakcijom.
Marković, Domagoj
core   +4 more sources

Predictors of cardiac function in acute heart failure patients with mid‐range ejection fraction: AURORA study

open access: yesESC Heart Failure, 2019
Aim The factors correlated with prognosis in heart failure with mid‐range ejection fraction (HFmrEF) is unclear, especially for acute heart failure (AHF) with HFmrEF.
Kyosuke Yanagawa   +14 more
doaj   +1 more source

Flexible wearable electronics for cardiovascular monitoring from surface signals to deep physiological insights

open access: yesFlexMat, EarlyView.
This review organizes flexible wearable electronics for cardiovascular monitoring into four interconnected information layers: surface electrophysiology, hemodynamic sensing, vascular imaging, and biofluid biomarker analysis. This framework clarifies how electrical rhythm, vascular loading, structural and flow‐related features, and biochemical states ...
Qiao Chen   +5 more
wiley   +1 more source

Human biomarker navigator

open access: yesiMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study

open access: yesBMC Cardiovascular Disorders
Background This study aimed to evaluate the effect of sacubitril valsartan (SV) on heart failure (HF) hospitalization and cardiovascular mortality in patients on hemodialysis with HF with preserved ejection fraction (EF; HFpEF).
Xiao-mei Huang   +9 more
doaj   +1 more source

The Endothelial CXCR Family in Vascular Health and Disease

open access: yesiNew Medicine, EarlyView.
ABSTRACT Endothelial cells (ECs) form the dynamic interface between blood and tissue, serving as key regulators of vascular homeostasis, inflammation, and repair. Among the molecular systems governing endothelial behavior, the C‐X‐C motif chemokine receptor (CXCR) family—originally characterized in immunology for its roles in leukocyte trafficking and ...
Zhiming Wu   +4 more
wiley   +1 more source

Heart failure with preserved ejection fraction: a nephrologist-directed primer [PDF]

open access: yes, 2017
There is substantial causal and consequential interaction between the ever-growing heart failure and renal failure patients. Half of the patients with heart failure (HF) have preserved left ventricular ejection fraction (HFpEF), which is difficult to ...
Alan Sag   +20 more
core   +2 more sources

β-blocker and 1-year outcomes among patients hospitalized for heart failure with mid-range ejection fraction. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother, 2022
Wang B   +7 more
europepmc   +1 more source

Prognostic Value of Epicardial Adipose Tissue in Heart Failure With Mid‐Range and Preserved Ejection Fraction: A Multicenter Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Epicardial adipose tissue (EAT) accumulation is thought to play a role in the pathophysiology of heart failure (HF) with mid‐range ejection fraction and HF with preserved ejection fraction, but its effect on outcome is unknown.
Wenxian Wang   +7 more
doaj   +1 more source

The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure [PDF]

open access: yes, 2012
Aims: Several models for predicting the prognosis of heart failure (HF) patients have been developed, but all of them focus on a single outcome variable, such as all-cause mortality.
Postmus, Douwe; id_orcid   +45 more
core   +2 more sources

Home - About - Disclaimer - Privacy